BRIAN WHITE: Open Payments
NPI 1003574765 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,172 in 104 payments from 15 companies in 2025. Trend: 2023 $2,722 · 2024 $1,725 · 2025 $2,172
Food & beverage: $2,034Education: $139
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $369 |
| Alkermes, Inc. | 26 | $305 |
| Teva Pharmaceuticals USA, Inc. | 11 | $288 |
| Axsome Therapeutics, Inc. | 8 | $253 |
| Neurocrine BioSciences, Inc. | 8 | $243 |
| Vanda Pharmaceuticals Inc. | 7 | $224 |
| E.R. Squibb & Sons, L.L.C. | 2 | $112 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Lundbeck LLC | 4 | $66 |
| Tris Pharma Inc | 2 | $54 |
Products named: VRAYLAR, INGREZZA, Auvelity, ARISTADA, AUSTEDO XR, FANAPT, COBENFY, REXULTI.
Industry payments across NC — which companies pay providers there.
